Regeneron is a biotechnology firm that develops innovative medicines for serious diseases, including eye conditions, cancer, and inflammatory disorders. Its therapies, like Eylea and Dupixent, help patients regain vision or manage chronic symptoms. Doctors and individuals with genetic or immune-related illnesses benefit most, as these treatments target underlying causes to improve quality of life.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends